Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.


EMUC 2018: POUT trial

Dr. Alison Birtle (UK) is thrilled about the results of the POUT trial. This trial examined the benefit of adjuvant chemotherapy after nephroureterectomy in patients with upper tract urothelial carcinoma.

  • Invited speakers

  • Alison Birtle, MD, PhD

    Urologist

    Lancashire Teaching Hospitals NHS. Royal Preston Hospital, UK

Related items